Nanotechnology approaches for the regeneration and neuroprotection of the central nervous system.
Nanotechnology is the science and engineering concerned with the design, synthesis, and characterization of materials and devices that have a functional organization in at least 1 dimension on the nanometer (ie, one-billionth of a meter) scale. The ability to manipulate and control engineered self-assembling (ie, self-organizing) substrates at these scales produces macroscopic physical and/or chemical properties in the bulk material not possessed by the constituent building block molecules alone. This in turn results in a degree of functional integration between the engineered substrates and cellular or physiological systems not previously attainable. Applied nanotechnology aimed at the regeneration and neuroprotection of the central nervous system (CNS) will significantly benefit from basic nanotechnology research conducted in parallel with advances in cell biology, neurophysiology, and neuropathology. Ultimately the goal is to develop novel technologies that directly or indirectly aid in providing neuroprotection and/or a permissive environment and active signaling cues for guided axon growth. In some cases, it is expected that the neurosurgeon will be required to administer these substrates to the patient. As such, in order for nanotechnology applications directed toward neurological disorders to develop to their fullest potential, it will be important for neuroscientists, neurosurgeons, and neurologists to participate and contribute to the scientific process alongside physical science and engineering colleagues. This review will focus on emerging clinical applications aimed at the regeneration and neuroprotection of the injured CNS, and discuss other platform technologies that have a significant potential for being adapted for clinical neuroscience applications.
Silva
Gabriel A
GA
Department of Bioengineering, Whitaker Institute for Biomedical Engineering, University of California, San Diego, CA 92037-0946, USA. gsilva@ucsd.edu
D001698:Biomedical Engineering / Q000639:trends*; D002490:Central Nervous System / Q000502:physiology; D002493:Central Nervous System Diseases / Q000517:prevention & control*; D006801:Humans; D036103:Nanotechnology / Q000639:trends*; D009416:Nerve Regeneration / Q000502:physiology*